GlassScriptPhysician profile
Peter Keyes Sculco
NPI 1699001909
$1,462,870.53
in general payments reported to CMS, 2019-2025
17 companies · $595K in 2025
The $595K reported for 2025 was more than what 97% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $52K · 2021: $257K · 2022: $88K · 2023: $126K · 2024: $269K · 2025: $595K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $782K · Education: $159K · Travel and Lodging: $36K · Food and Beverage: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $782,312.50 |
| Education | $159,383.25 |
| Travel and Lodging | $35,964.82 |
| Food and Beverage | $10,842.46 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,067,791.44 | 2019-2025 | Persona, Rosa, G7 |
| Encore Medical, LP | $199,516.88 | 2021 | |
| Medical Device Business Services, INC. | $74,456.91 | 2019-2025 | Actis |
| Limacorporate S.P.A. | $68,816.50 | 2019-2023 | Lantern Surgical Assistant |
| Intellijoint Surgical INC. | $26,517.32 | 2019-2025 | Intellijoint Hip, Intellijoint Hip, Intellijoint |
| Depuy Synthes Products, INC. | $6,184.02 | 2022 | |
| Lima USA, INC. | $5,049.06 | 2019-2023 | Lantern Surgical Assistant |
| Signature Orthopaedics USA Corp | $5,000.00 | 2023 | |
| Stryker Corporation | $4,648.87 | 2021-2022 | |
| Synthes Gmbh | $2,203.42 | 2023 | |
| Ignite Orthomotion LLC | $1,875.00 | 2023 | |
| Depuy Synthes Sales INC. | $594.39 | 2019-2025 | Inhance, Reclaim |
| Engage Uni, LLC | $114.00 | 2020 | |
| Restor3d, INC. | $45.00 | 2024 | |
| Heron Therapeutics, INC. | $29.07 | 2020-2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $28.65 | 2024 | Avance |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$329,629.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sculco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.